ANVS
Price
$2.74
Change
+$0.02 (+0.74%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
53M
82 days until earnings call
IPSC
Price
$0.56
Change
+$0.01 (+1.82%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
47.39M
83 days until earnings call
Interact to see
Advertisement

ANVS vs IPSC

Header iconANVS vs IPSC Comparison
Open Charts ANVS vs IPSCBanner chart's image
Annovis Bio
Price$2.74
Change+$0.02 (+0.74%)
Volume$13.15K
Capitalization53M
Century Therapeutics
Price$0.56
Change+$0.01 (+1.82%)
Volume$2.02K
Capitalization47.39M
ANVS vs IPSC Comparison Chart in %
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. IPSC commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (ANVS: $2.72 vs. IPSC: $0.55)
Brand notoriety: ANVS and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 40% vs. IPSC: 117%
Market capitalization -- ANVS: $53M vs. IPSC: $47.39M
ANVS [@Biotechnology] is valued at $53M. IPSC’s [@Biotechnology] market capitalization is $47.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 3 bullish, 5 bearish.
  • IPSC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ANVS and IPSC are a bad buy in the short-term.

Price Growth

ANVS (@Biotechnology) experienced а +4.62% price change this week, while IPSC (@Biotechnology) price change was +3.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.95%. For the same industry, the average monthly price growth was +21.44%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

ANVS is expected to report earnings on Nov 05, 2025.

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+5.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($53M) has a higher market cap than IPSC($47.4M). IPSC (-45.545) and ANVS (-45.924) have similar YTD gains . IPSC has higher annual earnings (EBITDA): -5.99M vs. ANVS (-25.17M). IPSC has more cash in the bank: 165M vs. ANVS (22.2M). IPSC has higher revenues than ANVS: IPSC (115M) vs ANVS (0).
ANVSIPSCANVS / IPSC
Capitalization53M47.4M112%
EBITDA-25.17M-5.99M420%
Gain YTD-45.924-45.545101%
P/E RatioN/AN/A-
Revenue0115M-
Total Cash22.2M165M13%
Total DebtN/A52.7M-
TECHNICAL ANALYSIS
Technical Analysis
ANVSIPSC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOIEF30.51N/A
N/A
Stolt-Nielsen Ltd
TRYIF6.63N/A
N/A
Toray Industries Inc.
SMOPF1.85N/A
N/A
SMARTOPTICS GROUP AS
SICLQ9.25N/A
N/A
Silvergate Capital Corporation
SCIA4.00-0.25
-5.88%
SCI Engineered Materials, Inc.

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+0.74%
ADXN - ANVS
43%
Loosely correlated
-0.24%
ATXS - ANVS
39%
Loosely correlated
-1.60%
AMLX - ANVS
38%
Loosely correlated
+1.33%
RXRX - ANVS
38%
Loosely correlated
-1.05%
IPSC - ANVS
38%
Loosely correlated
+3.15%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+3.15%
CRSP - IPSC
56%
Loosely correlated
+2.60%
ARWR - IPSC
53%
Loosely correlated
-6.05%
NTLA - IPSC
51%
Loosely correlated
-0.91%
IMNM - IPSC
50%
Loosely correlated
-0.70%
RXRX - IPSC
50%
Loosely correlated
-1.05%
More